{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:10:34Z","timestamp":1792757434513,"version":"4.5.0"},"reference-count":89,"publisher":"Georg Thieme Verlag KG","issue":"03","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Reprod Med"],"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Antiphospholipid syndrome (APS) is a disease characterized by the presence of antiphospholipid (aPL) antibodies, thrombosis, and obstetric complications. While patients with APS can have successful pregnancies, many important considerations exist. APS can also cooccur with other systemic autoimmune diseases which can affect pregnancy, particularly systemic lupus erythematosus. This article reviews specific considerations for pregnancy and reproductive health in patients with APS. Similar to other autoimmune diseases, stable or quiescent disease and planning with a rheumatologist and obstetrician prior to conception are vital components of a successful pregnancy. Pregnancy management for patients with aPL antibodies or diagnosis of APS with aspirin and\/or anticoagulation depending on disease profile is discussed, as well as the effects of physiologic changes during pregnancy in maternal and fetal outcomes for this population. Given the reproductive span lasts beyond conception through delivery, we include discussions on safe contraception options, the use of assistive reproductive technology, pregnancy termination, menopause, and male fertility. While APS is a relatively rare condition, the effects this disease can have on maternal and fetal outcomes even with available therapies demonstrates the need for more high-quality, evidence-based research.<\/jats:p>","DOI":"10.1055\/s-0044-1790225","type":"journal-article","created":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T23:02:48Z","timestamp":1729810968000},"page":"197-208","source":"Crossref","is-referenced-by-count":9,"title":["Impact of Antiphospholipid Syndrome on Reproductive Outcomes: Current Insights and Management Approaches"],"prefix":"10.1055","volume":"42","author":[{"given":"Lauren","family":"He","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, University of Michigan, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2890-4445","authenticated-orcid":false,"given":"Catherine","family":"Sims","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, University of Michigan, Ann Arbor, Michigan"},{"name":"Division of Rheumatology, Duke University, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2024,10,24]]},"reference":[{"issue":"02","key":"ref1","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"S Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"10","key":"ref2","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1002\/art.42624","article-title":"The 2023 ACR\/EULAR antiphospholipid syndrome classification criteria","volume":"75","author":"M Barbhaiya","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.3389\/fimmu.2018.02971","article-title":"Prevalence and significance of non-conventional antiphospholipid antibodies in patients with clinical APS criteria","volume":"9","author":"E Litvinova","year":"2018","journal-title":"Front Immunol"},{"issue":"09","key":"ref4","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1002\/art.40901","article-title":"The epidemiology of antiphospholipid syndrome: a population-based study","volume":"71","author":"A Duarte-Garc\u00eda","year":"2019","journal-title":"Arthritis Rheumatol"},{"issue":"02","key":"ref5","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/0961203310395053","article-title":"Antiphospholipid Syndrome Clinical Research Task Force report","volume":"20","author":"D Erkan","year":"2011","journal-title":"Lupus"},{"issue":"04","key":"ref6","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/acr.24130","article-title":"2020 American College of Rheumatology Guideline for the management of reproductive health in rheumatic and musculoskeletal diseases","volume":"72","author":"L R Sammaritano","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"03","key":"ref8","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/acr.25045","article-title":"2022 American College of Rheumatology Guideline for vaccinations in patients with rheumatic and musculoskeletal diseases","volume":"75","author":"A R Bass","year":"2023","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"02","key":"ref9","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/1756-185X.14490","article-title":"Evaluation of patients with antiphospholipid syndrome subsequently COVID-19 vaccinations: a retrospective cohort study","volume":"26","author":"\u00d6 Karaka\u015f","year":"2023","journal-title":"Int J Rheum Dis"},{"issue":"02","key":"ref10","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/rheumatology\/keac400","article-title":"COVID-19 vaccine affects neither prothrombotic antibody profile nor thrombosis in primary anti-phospholipid syndrome: a prospective study","volume":"62","author":"H Pan","year":"2023","journal-title":"Rheumatology (Oxford)"},{"issue":"01","key":"ref11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41232-022-00247-1","article-title":"Efficacy and risk of mRNA vaccination in patients with autoimmune inflammatory rheumatic diseases","volume":"43","author":"Y Kato","year":"2023","journal-title":"Inflamm Regen"},{"issue":"08","key":"ref12","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1177\/09612033221102073","article-title":"Immunogenicity, safety, and antiphospholipid antibodies after SARS-CoV-2 vaccine in patients with primary antiphospholipid syndrome","volume":"31","author":"F Signorelli","year":"2022","journal-title":"Lupus"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0140-6736(96)07113-9","article-title":"Risk of venous thromboembolism in users of hormone replacement therapy","volume":"348","author":"E Daly","year":"1996","journal-title":"Lancet"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"h4847","DOI":"10.1136\/bmj.h4847","article-title":"Contraceptive and hormonal treatment options for women with history of venous thromboembolism","volume":"351","author":"M C Stam-Slob","year":"2015","journal-title":"BMJ"},{"issue":"05","key":"ref16","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0010-7824(98)00041-9","article-title":"Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives. Results of an international, multicenter, case-control study","volume":"57","author":"World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception","year":"1998","journal-title":"Contraception"},{"issue":"11","key":"ref17","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1161\/ATVBAHA.110.211482","article-title":"The risk of deep venous thrombosis associated with injectable depot-medroxyprogesterone acetate contraceptives or a levonorgestrel intrauterine device","volume":"30","author":"A van Hylckama Vlieg","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"06","key":"ref18","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.contraception.2004.07.009","article-title":"Progestogen-only contraception in women at high risk of venous thromboembolism","volume":"70","author":"J Conard","year":"2004","journal-title":"Contraception"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"852777","DOI":"10.3389\/fcvm.2022.852777","article-title":"Risk of thrombosis, pregnancy morbidity or death in antiphospholipid syndrome","volume":"9","author":"M Killian","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"06","key":"ref20","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s11926-021-01006-w","article-title":"Which hormones and contraception for women with APS? Exogenous hormone use in women with APS","volume":"23","author":"L R Sammaritano","year":"2021","journal-title":"Curr Rheumatol Rep"},{"issue":"05","key":"ref21","doi-asserted-by":"crossref","first-page":"707","DOI":"10.3899\/jrheum.200802","article-title":"Lupus low disease activity state achievement is important for reducing adverse outcomes in pregnant patients with systemic lupus erythematosus","volume":"48","author":"J W Kim","year":"2021","journal-title":"J Rheumatol"},{"issue":"03","key":"ref22","doi-asserted-by":"crossref","first-page":"153","DOI":"10.7326\/M14-2235","article-title":"Predictors of pregnancy outcomes in patients with lupus: a cohort study","volume":"163","author":"J P Buyon","year":"2015","journal-title":"Ann Intern Med"},{"issue":"03","key":"ref23","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/annrheumdis-2016-209770","article-title":"EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and\/or antiphospholipid syndrome","volume":"76","author":"L Andreoli","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"ref24","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1136\/annrheumdis-2019-215213","article-title":"EULAR recommendations for the management of antiphospholipid syndrome in adults","volume":"78","author":"M G Tektonidou","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"04","key":"ref25","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0015-0282(16)58565-3","article-title":"Antiphospholipid antibody panels and recurrent pregnancy loss: prevalence of anticardiolipin antibodies compared with other antiphospholipid antibodies","volume":"66","author":"D L Yetman","year":"1996","journal-title":"Fertil Steril"},{"issue":"06","key":"ref26","doi-asserted-by":"crossref","first-page":"470","DOI":"10.7326\/0003-4819-120-6-199403150-00004","article-title":"Antiphospholipid antibodies in predicting adverse pregnancy outcome. A prospective study","volume":"120","author":"A Lynch","year":"1994","journal-title":"Ann Intern Med"},{"issue":"07","key":"ref27","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1055\/s-0036-1592336","article-title":"Pregnancy and antiphospholipid syndrome","volume":"42","author":"K Schreiber","year":"2016","journal-title":"Semin Thromb Hemost"},{"issue":"03","key":"ref28","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/00008469-200206000-00012","article-title":"Correlates of pregnancy oestrogen, progesterone and sex hormone-binding globulin in the USA and China","volume":"11","author":"J Wuu","year":"2002","journal-title":"Eur J Cancer Prev"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"516420","DOI":"10.1155\/2013\/516420","article-title":"The role of thrombophilia in pregnancy","volume":"2013","author":"E M Battinelli","year":"2013","journal-title":"Thrombosis"},{"issue":"01","key":"ref30","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ajog.2004.11.037","article-title":"Thrombosis during pregnancy and the postpartum period","volume":"193","author":"A H James","year":"2005","journal-title":"Am J Obstet Gynecol"},{"issue":"10","key":"ref31","doi-asserted-by":"crossref","first-page":"697","DOI":"10.7326\/0003-4819-143-10-200511150-00006","article-title":"Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study","volume":"143","author":"J A Heit","year":"2005","journal-title":"Ann Intern Med"},{"issue":"04","key":"ref32","doi-asserted-by":"crossref","first-page":"101319","DOI":"10.1016\/j.ajogmf.2024.101319","article-title":"Maternal cardiovascular events in autoimmune rheumatic diseases and antiphospholipid syndrome pregnancies","volume":"6","author":"R Dhital","year":"2024","journal-title":"Am J Obstet Gynecol MFM"},{"issue":"04","key":"ref33","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1053\/j.semperi.2019.03.004","article-title":"Venous thromboembolism as a cause of severe maternal morbidity and mortality in the United States","volume":"43","author":"K Abe","year":"2019","journal-title":"Semin Perinatol"},{"issue":"01","key":"ref34","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1053\/j.semperi.2017.11.006","article-title":"Catastrophic antiphospholipid syndrome and pregnancy","volume":"42","author":"R M Silver","year":"2018","journal-title":"Semin Perinatol"},{"issue":"04","key":"ref35","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/art.10187","article-title":"Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients","volume":"46","author":"R Cervera","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"12","key":"ref36","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.autrev.2016.09.010","article-title":"Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of 500 patients from the International CAPS Registry","volume":"15","author":"I Rodr\u00edguez-Pint\u00f3","year":"2016","journal-title":"Autoimmun Rev"},{"issue":"07","key":"ref37","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1161\/CIRCRESAHA.118.313276","article-title":"Preeclampsia: pathophysiology, challenges, and perspectives","volume":"124","author":"S Rana","year":"2019","journal-title":"Circ Res"},{"issue":"03","key":"ref38","first-page":"392","article-title":"Evaluation of total LDH and its isoenzymes as markers in preeclampsia","volume":"39","author":"F R Saleem","year":"2020","journal-title":"J Med Biochem"},{"issue":"02","key":"ref39","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/10641950802601187","article-title":"CA-125 and CRP are elevated in preeclampsia","volume":"28","author":"F B Cebesoy","year":"2009","journal-title":"Hypertens Pregnancy"},{"issue":"17","key":"ref40","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1080\/14767058.2019.1671339","article-title":"Uric acid levels in gestational hypertensive women predict preeclampsia and outcome of small-for-gestational-age infants","volume":"34","author":"X Zhao","year":"2021","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref41","volume-title":"Preeclampsia","author":"S A Karrar"},{"issue":"03","key":"ref42","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.transci.2015.11.005","article-title":"Pregnancy associated thrombotic thrombocytopenic purpura: practical issues for patient management","volume":"53","author":"C Savignano","year":"2015","journal-title":"Transfus Apher Sci"},{"issue":"01","key":"ref43","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1182\/asheducation-2018.1.530","article-title":"Clinical and laboratory diagnosis of TTP: an integrated approach","volume":"2018","author":"T Chiasakul","year":"2018","journal-title":"Hematology (Am Soc Hematol Educ Program)"},{"issue":"01","key":"ref44","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3390\/ijerph16010109","article-title":"Diagnosis of HELLP syndrome: a 10-year survey in a perinatology centre","volume":"16","author":"K Rimaitis","year":"2019","journal-title":"Int J Environ Res Public Health"},{"issue":"03","key":"ref45","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/jog.13532","article-title":"Serum amyloid A, procalcitonin, highly sensitive C reactive protein and tumor necrosis factor alpha levels and acute inflammatory response in patients with hemolysis, elevated liver enzymes, low platelet count (HELLP) and eclampsia","volume":"44","author":"K Uckan","year":"2018","journal-title":"J Obstet Gynaecol Res"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2393-9-8","article-title":"The HELLP syndrome: clinical issues and management. A review","volume":"9","author":"K Haram","year":"2009","journal-title":"BMC Pregnancy Childbirth"},{"issue":"08","key":"ref47","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1093\/oxfordjournals.humrep.a136224","article-title":"Antiphospholipid antibodies and beta 2-glycoprotein-I in 500 women with recurrent miscarriage: results of a comprehensive screening approach","volume":"10","author":"R S Rai","year":"1995","journal-title":"Hum Reprod"},{"issue":"07","key":"ref48","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1002\/art.34402","article-title":"Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies","volume":"64","author":"M D Lockshin","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"09","key":"ref49","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1093\/rheumatology\/ker139","article-title":"Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case-control study","volume":"50","author":"A Ruffatti","year":"2011","journal-title":"Rheumatology (Oxford)"},{"issue":"03","key":"ref50","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s11926-007-0035-9","article-title":"Do antiphospholipid antibodies cause preeclampsia and HELLP syndrome?","volume":"9","author":"E A Clark","year":"2007","journal-title":"Curr Rheumatol Rep"},{"issue":"04","key":"ref51","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/S0002-9378(97)70294-1","article-title":"Antiphospholipid immunoglobulin G antibodies reduce annexin-V levels on syncytiotrophoblast apical membranes and in culture media of placental villi","volume":"177","author":"J H Rand","year":"1997","journal-title":"Am J Obstet Gynecol"},{"issue":"06","key":"ref52","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrrheum.2011.52","article-title":"Pathogenesis of antiphospholipid syndrome: understanding the antibodies","volume":"7","author":"P L Meroni","year":"2011","journal-title":"Nat Rev Rheumatol"},{"issue":"06","key":"ref53","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1007\/s00404-022-06864-y","article-title":"New advances in prediction and surveillance of preeclampsia: role of machine learning approaches and remote monitoring","volume":"308","author":"M Hackel\u00f6er","year":"2023","journal-title":"Arch Gynecol Obstet"},{"issue":"05","key":"ref54","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrrheum.2015.29","article-title":"The clinical spectrum of autoimmune congenital heart block","volume":"11","author":"P Brito-Zer\u00f3n","year":"2015","journal-title":"Nat Rev Rheumatol"},{"issue":"12","key":"ref55","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1001\/jama.2021.8551","article-title":"Aspirin use to prevent preeclampsia and related morbidity and mortality: updated evidence report and systematic review for the US Preventive Services Task Force","volume":"326","author":"J T Henderson","year":"2021","journal-title":"JAMA"},{"issue":"07","key":"ref56","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia","volume":"377","author":"D L Rolnik","year":"2017","journal-title":"N Engl J Med"},{"issue":"02","key":"ref57","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/rheumatology\/kep373","article-title":"Combination of heparin and aspirin is superior to aspirin alone in enhancing live births in patients with recurrent pregnancy loss and positive anti-phospholipid antibodies: a meta-analysis of randomized controlled trials and meta-regression","volume":"49","author":"A Mak","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"ref58","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/S1701-2163(16)34689-8","article-title":"The \u201cwarfarin window\u201d in pregnancy: the importance of half-life","volume":"32","author":"A Walfisch","year":"2010","journal-title":"J Obstet Gynaecol Can"},{"issue":"01","key":"ref59","doi-asserted-by":"crossref","first-page":"e000651","DOI":"10.1136\/lupus-2021-000651","article-title":"Hydroxychloroquine in the pregnancies of women with lupus: a meta-analysis of individual participant data","volume":"9","author":"M EB Clowse","year":"2022","journal-title":"Lupus Sci Med"},{"issue":"02","key":"ref60","doi-asserted-by":"crossref","first-page":"273.e1","DOI":"10.1016\/j.ajog.2015.09.078","article-title":"The impact of hydroxychloroquine treatment on pregnancy outcome in women with antiphospholipid antibodies","volume":"214","author":"S Sciascia","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"02","key":"ref61","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1538-7836.2009.03674.x","article-title":"Clinical course of high-risk patients diagnosed with antiphospholipid syndrome","volume":"8","author":"V Pengo","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"01","key":"ref62","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/s12884-023-05561-1","article-title":"Specific changes and clinical significance of plasma D-dimer during pregnancy and puerperium: a prospective study","volume":"23","author":"Q Xu","year":"2023","journal-title":"BMC Pregnancy Childbirth"},{"issue":"06","key":"ref63","first-page":"10","article-title":"Use of D-dimer measurement to guide anticoagulant treatment in recurrent pregnancy loss associated with antiphospholipid syndrome","volume":"78","author":"S H Bao","year":"2017","journal-title":"Am J Reprod Immunol"},{"issue":"03","key":"ref64","first-page":"10","article-title":"D-dimer assay may guide LMWH treatment in repeated biochemical pregnancy losses in women with positive antiphospholipid antibody","volume":"66","author":"S H Bao","year":"2020","journal-title":"Clin Lab"},{"issue":"03","key":"ref65","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1590\/0100-3984.2019.0059","article-title":"Imaging evaluation of nonobstetric conditions during pregnancy: what every radiologist should know","volume":"53","author":"A PC Rocha","year":"2020","journal-title":"Radiol Bras"},{"issue":"14","key":"ref66","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1056\/NEJMoa1311485","article-title":"Risk of a thrombotic event after the 6-week postpartum period","volume":"370","author":"H Kamel","year":"2014","journal-title":"N Engl J Med"},{"issue":"09","key":"ref69","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1182\/blood.2023020727","article-title":"How I diagnose and treat antiphospholipid syndrome in pregnancy","volume":"143","author":"D W Branch","year":"2024","journal-title":"Blood"},{"key":"ref71","volume-title":"Postpartum Depression","author":"S Mughal"},{"issue":"10","key":"ref72","first-page":"2487","article-title":"Increased risk of postpartum depression in","volume":"68","author":"E Vinet","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"02","key":"ref73","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s12016-007-0010-2","article-title":"Anti-phospholipid antibodies and infertility","volume":"32","author":"H J Carp","year":"2007","journal-title":"Clin Rev Allergy Immunol"},{"issue":"10","key":"ref74","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1055\/s-0039-1697982","article-title":"Antiphospholipid antibody syndrome and infertility","volume":"41","author":"V O Rodrigues","year":"2019","journal-title":"Rev Bras Ginecol Obstet"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jri.2008.11.005","article-title":"A critical assessment of the role of antiphospholipid antibodies in infertility","volume":"80","author":"K L Buckingham","year":"2009","journal-title":"J Reprod Immunol"},{"issue":"03","key":"ref76","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1053\/sarh.2002.37212","article-title":"Importance of planning ovulation induction therapy in systemic lupus erythematosus and antiphospholipid syndrome: a single center retrospective study of 21 cases and 114 cycles","volume":"32","author":"D L Huong","year":"2002","journal-title":"Semin Arthritis Rheum"},{"issue":"08","key":"ref77","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1002\/art.41249","article-title":"Elective termination of pregnancy in autoimmune rheumatic diseases: experience from two databases","volume":"72","author":"M D Lockshin","year":"2020","journal-title":"Arthritis Rheumatol"},{"issue":"02","key":"ref78","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.contraception.2021.03.016","article-title":"Society of Family Planning clinical recommendations: management of individuals with bleeding or thrombotic disorders undergoing abortion","volume":"104","author":"J K Lee","year":"2021","journal-title":"Contraception"},{"issue":"01","key":"ref79","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.contraception.2017.09.002","article-title":"Blood loss at the time of dilation and evacuation at 16 to 22 weeks of gestation in women using low molecular weight heparin: a case series","volume":"97","author":"M Tschann","year":"2018","journal-title":"Contraception"},{"issue":"03","key":"ref80","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1177\/0961203319828507","article-title":"Levels of anti-M\u00fcllerian hormone in premenopausal women with the antiphospholipid syndrome and its association with the risk of clinical complications","volume":"28","author":"D Castillo-Mart\u00ednez","year":"2019","journal-title":"Lupus"},{"issue":"04","key":"ref81","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/aji.12551","article-title":"Anti-Mullerian hormone levels decline with the presence of antiphospholipid antibodies","volume":"76","author":"M Vega","year":"2016","journal-title":"Am J Reprod Immunol"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.autrev.2014.01.003","article-title":"Autoimmune primary ovarian insufficiency","volume":"13","author":"C A Silva","year":"2014","journal-title":"Autoimmun Rev"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejogrb.2023.09.025","article-title":"Sexual health in women with Sjogren's syndrome: a review","volume":"291","author":"Y Yang","year":"2023","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"05","key":"ref84","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1007\/s10067-024-06934-3","article-title":"A predictive model for premature atherosclerosis in systemic lupus erythematosus based on clinical characteristics","volume":"43","author":"R Liang","year":"2024","journal-title":"Clin Rheumatol"},{"issue":"S 01","key":"ref85","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s43465-023-01024-z","article-title":"Osteoporosis in rheumatology","volume":"57","author":"S Chandrashekara","year":"2023","journal-title":"Indian J Orthop"},{"issue":"02","key":"ref86","first-page":"86","article-title":"Clinical implications of systemic lupus erythematosus without and with antiphospholipid syndrome in peri- and postmenopausal age","volume":"17","author":"B Grygiel-G\u00f3rniak","year":"2018","journal-title":"Przegl Menopauz"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3389\/fendo.2019.00265","article-title":"Autoimmune disease in women: endocrine transition and risk across the lifespan","volume":"10","author":"M K Desai","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.maturitas.2021.09.004","article-title":"Impact of menopause on women with systemic lupus erythematosus","volume":"154","author":"C A Karvonen-Gutierrez","year":"2021","journal-title":"Maturitas"},{"issue":"01","key":"ref89","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/01.AOG.0000441353.20693.78","article-title":"ACOG Practice Bulletin No. 141: management of menopausal symptoms","volume":"123","author":"ACOG Practice Bulletin No","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"01","key":"ref90","first-page":"e52467","article-title":"Nonhormonal pharmacotherapies for the treatment of postmenopausal vasomotor symptoms","volume":"16","author":"T Witten","year":"2024","journal-title":"Cureus"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"932181","DOI":"10.3389\/fimmu.2022.932181","article-title":"Relationship between gender differences and clinical outcome in patients with the antiphospholipid syndrome","volume":"13","author":"S Truglia","year":"2022","journal-title":"Front Immunol"},{"issue":"01","key":"ref92","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1038\/s41598-018-19761-9","article-title":"Chemotherapy drugs cyclophosphamide, cisplatin and doxorubicin induce germ cell loss in an in vitro model of the prepubertal testis","volume":"8","author":"E Smart","year":"2018","journal-title":"Sci Rep"},{"issue":"34","key":"ref93","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/jncimonographs\/lgi001","article-title":"Relative susceptibilities of male germ cells to genetic defects induced by cancer chemotherapies","author":"A J Wyrobek","year":"2005","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"07","key":"ref94","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1002\/art.22660","article-title":"Gonad evaluation in male systemic lupus erythematosus","volume":"56","author":"P M Soares","year":"2007","journal-title":"Arthritis Rheum"}],"container-title":["Seminars in Reproductive Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0044-1790225.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T23:53:36Z","timestamp":1734047616000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0044-1790225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":89,"journal-issue":{"issue":"03","published-online":{"date-parts":[[2024,12,12]]},"published-print":{"date-parts":[[2024,9]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0044-1790225","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["1526-8004","1526-4564"],"issn-type":[{"value":"1526-8004","type":"print"},{"value":"1526-4564","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9]]}}}